Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder

Inclusion Criteria: * Adult patients with schizophrenia or bipolar 1 disorder * Patients who are prescribed Abilify Maintena® Injections treatment as per investigator's medical judgment * Patients giving written authorization to use their personal and health data and starting Abilify Maintena® Injections treatment after agreement is in place and investigators provide the explanation about objective and feature of the surveillance Exclusion Criteria: * Patients with known hypersensitivity to Aripiprazole or any excipients of Abilify Maintena® Injections * Elderly patients with dementia related psychosis * Patients who have been treated with Abilify Maintena® Injections * Patients with score 0(Not assessed) or 1(Normal, not at all ill) in the Clinical Global Impression-Severity(CGI-S) * Patients participating in other clinical trial * All patients who in medical judgment of the investigator would not be appropriate for inclusion criteria in the surveillance